A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says April 04, 2024 Amyotrophic Lateral Sclerosis Brain Clinical Trials Corporations Drugs (Pharmaceuticals) NYT NYTimes Suits and Litigation (Civil) your-feed-healthcare your-feed-science +
Scientists Scramble to Keep Dog Aging Project Alive January 11, 2024 Age Amyotrophic Lateral Sclerosis Chronological Dementia Dogs Longevity NYT NYTimes Pets your-feed-health your-feed-science +
New Experimental Therapy for A.L.S. Approved in Canada June 13, 2022 Amyotrophic Lateral Sclerosis Clinical Trials Drugs (Pharmaceuticals) Health IFTTT NYT NYTimes your-feed-science +
New A.L.S. Treatment Lacks Evidence of Benefit, F.D.A. Panel Finds March 30, 2022 Amyotrophic Lateral Sclerosis Clinical Trials Drugs (Pharmaceuticals) Health IFTTT NYT NYTimes Placebos Research your-feed-healthcare your-feed-science +
Drug May Extend A.L.S. Patients’ Lives by Several Months, Study Finds October 16, 2020 Amyotrophic Lateral Sclerosis Clinical Trials Drugs (Pharmaceuticals) Health IFTTT NYT NYTimes Research your-feed-healthcare +
2 College Students Dreamed Up an A.L.S. Treatment. The Results Are In. September 02, 2020 Amyotrophic Lateral Sclerosis Clinical Trials Drugs (Pharmaceuticals) Health IFTTT NYT NYTimes Research your-feed-healthcare +